BROSSARD, QUEBEC, CANADA--(Marketwire - Sept. 27, 2012) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, announced today the signature of a second agreement for the use of its CARDS (Computer Aided Resource Detection System) technology, to generate potential exploration targets on Codelco's (Corporacion Nacional del Cobre de Chile) exploration programs in Chile.
DIAGNOS will assist Codelco in identifying targets by using its CARDS technology, which makes possible the identification of sites having the same signature as known mineralized occurrences. DIAGNOS uses its proprietary technology to analyze geological, geophysical and geochemical to enable the identification of patterns hidden in the large amount of data each customer owns.
DIAGNOS can count on a multidisciplinary team that includes professionals in geophysics, geology, Artificial Intelligence, mathematics, as well as remote sensing and image interpretation.
Codelco is the world´s largest copper producer, is headquartered in the Chile. In 2011 Codelco produced 1,796,000 tons of copper, 11% of total world copper production (including its share in El Abra mine). It is also one of the top companies in molybdenum production, with 23,098 metric tons during this period. Codelco is a 100% state-owned company and it has the largest copper reserves and resources known in the world. Codelco´s sales in 2011 were US$17,515 million.
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE:ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare, natural resources.
The Corporation's objective is to develop a royalty stream by significantly enhancing and participating in the exploration success rate of mining.
For more information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.